FDA Inspection 1248982 — Angela L. Gentile, M.D.
The FDA completed an inspection of Angela L. Gentile, M.D. on Aug 23, 2024 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Buenos Aires (Argentina)
Additional details
Clinical Investigator (CI)